F4 FundFund
TeamPortfolioRaiseEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesSimilar Firms
Hot Fund

CommonKind VC

commonkind.vc · Los Angeles, CA

Investment thesis

Back founders who expand the common good for humankind, starting with healthcare, using data to improve care delivery efficiency, care quality and the toolkit that defines what care can be.

$150K – $750K
Check Size
01Investment Thesis

Back founders who expand the common good for humankind, starting with healthcare, using data to improve care delivery efficiency, care quality and the toolkit that defines what care can be.

02Investment Team
BY
Bryan Yoo
General Partner
03F4 Research Brief

CommonKind VC Research

Investment Thesis

CommonKind (stylized "commonkind vc") is a pre-seed and seed stage venture fund that backs founders who expand the common good for humankind, starting with healthcare. The firm invests in technologies that harness data to do three things: drive scalable improvements in the efficiency of care delivery, enable fundamental advances in the quality and effectiveness of care, and push the frontier and expand the toolkit that defines what care can be. Its website describes the fund as investing across healthcare and life sciences, favoring companies that are AI native, workflow embedded and vertically integrated.

Stage Focus

CommonKind invests at pre-seed and seed. It is a new fund, founded in 2025, and participated in a later-stage round alongside other healthcare investors in November 2026.

Check Size

CommonKind does not publish its check size. Third-party fund databases estimate an initial check of roughly $150K to $750K, which is an estimate and not a figure the firm states.

Lead Tendency

CommonKind's only publicly reported investment, Akara, was a round led by Locke Health, with CommonKind participating. The firm has not stated whether it leads rounds.

Recent Activity

In November 2026, Akara, a Dublin-based hospital operations technology company and Trinity College Dublin spinout, announced $5.5 million in venture funding, bringing its total raised to $12.3 million. The round was led by Locke Health, with participation from VTC Ventures, the EIC Fund, CommonKind and NovaVector Holdings, alongside existing investors ACT, Atlantic Bridge and Enterprise Ireland. Akara combines privacy-preserving sensing, AI and robotics to reduce hospital administrative work, coordinate services and treat more patients.

Regulatory filings show an investment vehicle, Commonkind 1, LP, with a 2025 vintage and a reported $15 million offered and sold. The firm has not published fund size on its own site.

Portfolio Highlights

The only investment CommonKind has disclosed publicly is Akara (healthcare operations automation, Ireland). The firm does not publish a portfolio page.

Team

  • Bryan Yoo, General Partner: Founder of the fund and former co-founder and CEO of Nuanced Health, a preclinical R&D company. He holds a PhD in Cellular and Molecular Neurobiology and an undergraduate degree from Stanford University. Based in California.

CommonKind lists no other team members publicly.

Decision Process

The fund appears to be run by a single general partner, so decisions are most likely made by Bryan Yoo alone. The firm has not described its process.

Founder Preferences

CommonKind backs founders building healthcare and life sciences technology that uses data to make care delivery more efficient, improve outcomes or expand what care can do. It favors companies whose products are AI native, embedded in clinical or operational workflows, and vertically integrated. Founders with healthcare or life sciences operating backgrounds fit the profile of the GP himself.

Geographic Focus

The fund is based in Los Angeles, California. It describes no geographic limit, and its one reported investment is in Ireland, so it invests beyond North America.

CommonKind does not publish the stage or date of most of its activity, and its website carries only a short description and a link to the GP's LinkedIn profile.

04Selected Portfolio
Enterprise Software
Akara
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

Participated in Akara's $5.5M round, led by Locke Health, for privacy-preserving AI in hospitals.
INVESTMENT·tcd.ie+1
NOV 2026
06Similar Firms
BH
Bertelsmann Healthcare Investments
Pre-Seed · Seed
→
LV
Layout Ventures
$250K · Pre-Seed · Seed
→
HC
Healthier Capital
Seed · Series A
→
A
Averin
$500K – $10M · Pre-Seed · Seed
→
BO
Black Opal Ventures
$250K – $2M · Seed · Series A
→
Quick Reference
Check Size
$150K – $750K
Stages
Pre-Seed · Seed
Decision
Solo GP
Location
Los Angeles, CA
Sector Focus
Biotech & Life SciencesHealthcare & Digital Health
Models
AI-NativeWorkflow-EmbeddedVertically Integrated
Technology
AI/MLHealthcare Data
See all Biotech & Life Sciences investors →See all Healthcare & Digital Health investors →
Visit commonkind.vc ↗

See how CommonKind VC matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Biotech & Life SciencesHealthcare & Digital Health

See how CommonKind VC matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched November 21, 2026F4 Research Engine